The Latest Analyst Ratings For Progyny
Progyny Cut to Neutral From Overweight by JP Morgan
Progyny Price Target Cut to $17.00/Share From $22.00 by JP Morgan
J.P. Morgan Downgrades Progyny(PGNY.US) to Hold Rating, Announces Target Price $17
Progyny's Short-Term Challenges and Long-Term Promise: A Hold Rating Amidst Market Pressures
Progyny Is Maintained at Overweight by Barclays
Progyny Analyst Ratings
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $17 to $22
Jefferies Adjusts Progyny Price Target to $19 From $24, Maintains Buy Rating
Progyny Is Maintained at Hold by Canaccord Genuity
Progyny Price Target Cut to $17.00/Share From $18.00 by Canaccord Genuity
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $19 to $30
Progyny Analyst Ratings
Progyny's Strong Market Position and Growth Potential Justifies Buy Rating Despite Utilization Challenges
Progyny Downgraded to Hold From Buy at Truist
Barclays Issues a Buy Rating on Progyny (PGNY)
Progyny (PGNY) Receives a Hold From JMP Securities
Progyny Analyst Ratings
KeyBanc Maintains Progyny(PGNY.US) With Hold Rating
Truist Financial Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $26